HNRNPA1 and colorectal carcinoma: A combination of actions of a plant-based compound, kaempferol, and miR activity modulation was also demonstrated for the recently described miR-339-5p-hnRNPA1/PTBP1-PKM2 axis, which inhibits glycolysis and CRC growth.